Rankings
▼
Calendar
ADMA FY 2023 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena
ADMA
ADMA Biologics, Inc.
$4B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$258M
+67.6% YoY
Gross Profit
$89M
34.4% margin
Operating Income
$22M
8.4% margin
Net Income
-$28M
-10.9% margin
EPS (Diluted)
$-0.13
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$4M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$329M
Total Liabilities
$194M
Stockholders' Equity
$135M
Cash & Equivalents
$51M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$258M
$154M
+67.6%
Gross Profit
$89M
$35M
+152.2%
Operating Income
$22M
-$39M
+155.0%
Net Income
-$28M
-$66M
+57.2%
← Q4 2022
All Quarters
Q1 2023 →